These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19627460)

  • 1. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit.
    Alarma-Estrany P; Crooke A; Pintor J
    J Pineal Res; 2009 Sep; 47(2):201-209. PubMed ID: 19627460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand.
    Vincent L; Cohen W; Delagrange P; Boutin JA; Nosjean O
    J Pineal Res; 2010 Apr; 48(3):222-229. PubMed ID: 20210850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
    Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
    Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pineal Res; 2012 Apr; 52(3):265-70. PubMed ID: 22107075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
    Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde R; Pelaez T; Yerxa B; Pintor J
    J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes.
    Andrés-Guerrero V; Molina-Martínez IT; Peral A; de las Heras B; Pintor J; Herrero-Vanrell R
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1507-15. PubMed ID: 21087964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes.
    Serle JB; Wang RF; Peterson WM; Plourde R; Yerxa BR
    J Glaucoma; 2004 Oct; 13(5):385-8. PubMed ID: 15354076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits.
    Pintor J; Martin L; Pelaez T; Hoyle CH; Peral A
    Eur J Pharmacol; 2001 Mar; 416(3):251-4. PubMed ID: 11290376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.
    Pintor J; Peláez T; Hoyle CH; Peral A
    Br J Pharmacol; 2003 Mar; 138(5):831-6. PubMed ID: 12642384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unexpected effect of 5-MCA-NAT in chick retinal development.
    Sampaio Lde F
    Int J Dev Neurosci; 2009 Oct; 27(6):511-5. PubMed ID: 19596433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice.
    Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Pintor J
    J Pharmacol Exp Ther; 2016 May; 357(2):293-9. PubMed ID: 26941171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells.
    Huete-Toral F; Crooke A; Martínez-Águila A; Pintor J
    J Pharmacol Exp Ther; 2015 Jan; 352(1):119-28. PubMed ID: 25344385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment.
    Crooke A; Huete-Toral F; Martínez-Águila A; Alarma-Estrany P; Pintor J
    Pharmacogenet Genomics; 2011 Sep; 21(9):587-9. PubMed ID: 21705965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3.
    Mailliet F; Ferry G; Vella F; Thiam K; Delagrange P; Boutin JA
    FEBS Lett; 2004 Dec; 578(1-2):116-20. PubMed ID: 15581627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells.
    Dortch-Carnes J; Tosini G
    Exp Eye Res; 2013 Feb; 107():1-10. PubMed ID: 23201027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites.
    Molinari EJ; North PC; Dubocovich ML
    Eur J Pharmacol; 1996 Apr; 301(1-3):159-68. PubMed ID: 8773460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in melatonin receptor expression in a murine model of glaucoma.
    Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Carracedo G; Pintor J
    Mol Vis; 2020; 26():530-539. PubMed ID: 32818016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The melatonin analog 5-MCA-NAT increases endogenous dopamine levels by binding NRH:quinone reductase enzyme in the developing chick retina.
    Sampaio Lde F; Mesquita FP; de Sousa PR; Silva JL; Alves CN
    Int J Dev Neurosci; 2014 Nov; 38():119-26. PubMed ID: 25218627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Melatonin and Its Analogs on Tear Secretion.
    Navarro Gil FJ; Huete-Toral F; Crooke A; Dominguez Godinez CO; Carracedo G; Pintor J
    J Pharmacol Exp Ther; 2019 Oct; 371(1):186-190. PubMed ID: 31371479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.